Subfulminant liver failure associated with quetiapine

European Journal of Gastroenterology and Hepatology

Volumn 16, Issue 12, 2004, Pages 1415-1418

  El Hajj, Ihab ^a   Sharara, Ala I ^a,b   Rockey, Don C ^b  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adverse effect; Bipolar disorder; DILI; Drug induced liver injury; Encephalopathy; Hepatotoxicity; RUCAM

Indexed keywords

LITHIUM; QUETIAPINE;

ADULT; ARTICLE; BIPOLAR DISORDER; CASE REPORT; CLINICAL FEATURE; DRUG INDUCED DISEASE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY DIAGNOSIS; LIVER FAILURE; LIVER INJURY; LIVER TOXICITY; PRIORITY JOURNAL; SUBFULMINANT LIVER FAILURE;

ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DIBENZOTHIAZEPINES; FATAL OUTCOME; FEMALE; HUMANS; LIVER FAILURE; MIDDLE AGED;

EID: 10344248929     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200412000-00029     Document Type: Article

References (20)

1. Schiodt FV, Atillasoy E, Shakil AO, Schiff ER, Caldwell C, Kowdley KV, et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transplant Surg 1999; 5:29-34.
2. Shakil AO, Kramer D, Mazariegos MG, Fung JJ, Rakela J. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 2000; 6:163-169.
3. Lacy C, Armstrong L, Goldman M, Lance L. Quetiapine. In: Drug Information Handbook. 9th edn. Ohio: Lexi-Comp Inc.; 2001-2002, pp. 1046-1047.
4. Mullen J, Jibson MD, Sweitzer D. A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the quetiapine experience with safety and tolerability (QUEST) study. Clin Ther 2001; 23: 1839-1854.
5. Bourgeois JA, Babine S, Meyerovich M, Doyle J. A case of neuroleptic malignant syndrome with quetiapine. J Neuropsychiatry Clin Neurosci 2002; 14:87.
6. Alexiadis M, Whitehorn D, Woodley H, Kopala L. Prolactin elevation with quetiapine. Am J Psychiatry 2002; 159:1608-1609.
7. Gajwani P, Pozuelo L, Tesar GE. QT interval prolongation associated with quetiapine (Seroquel) overdose. Psychosomatics 2000; 41:63-65.
8. Garver DL. Review of quetiapine side effects. J Clin Psychiatry 2000; 61 (suppl 8):31-33; discussion 34-35.
9. Domon SE, Cargile CS. Quetiapine-associated hyperglycemia and hypertriglyceridemia. J Am Acad Child Adolesc Psychiatry 2002; 41: 495-496.
10. Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis 1986; 6:97-106.
11. Ostapowicz G, Fontana RJ, Schiodt MD, Larson A, Davern TJ, Han SHB, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137:947-954.
12. Benichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol 1990; 11:272-276.
13. Maria VA, Victorino RM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology 1997; 26:664-669.
14. Yeung E, Wong FS, Wanless IR, Shiota K, Guindi M, Joshi S, Gardiner G. Ramipril-associated hepatotoxicity. Arch Pathol Lab Med 2003; 127:1493-1497.
15. Nammour FE, Fayad NF, Peikin SR. Metformin-induced cholestatic hepatitis. Endocr Pract 2003; 9:307-309.
16. Larrey D. Epidemiology and individual susceptibility to adverse drug reactions affecting the liver. Semin Liv Dis 2002; 22:145-155.
17. Danan G, Benichou C. Causality assessment of adverse reactions to drugs - I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries, J Clin Epidemiol 1993; 46:1323-1330.
18. Benichou C, Danan G, Flahault A. Causality assessment of adverse reactions to drugs - II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. J Clin Epidemiol 1993; 46:1331-1336.
19. Zimmerman HJ. Drug-induced liver disease. Clin Liver Dis 2000; 4: 73-96, vi.
20. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97:439-445.